CWG
C WorldWide Group Portfolio holdings
AUM
$7.38B
This Quarter Return
-9.76%
1 Year Return
+18.35%
3 Year Return
+71.53%
5 Year Return
+105.42%
10 Year Return
+360.65%
AUM
$9.18B
AUM Growth
+$9.18B
(-13%)
Cap. Flow
-$266M
Cap. Flow
% of AUM
-2.9%
Top 10 Holdings %
Top 10 Hldgs %
72.26%
Holding
94
New
1
Increased
30
Reduced
30
Closed
10
Top Buys
| 1 |
OSH
Oak Street Health, Inc.
OSH
|
$8.06M |
| 2 |
Teladoc Health
TDOC
|
$5.77M |
| 3 |
NovoCure
NVCR
|
$4.56M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$4.21M |
| 5 |
Krystal Biotech
KRYS
|
$2.66M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
$29.4M |
| 2 |
Thermo Fisher Scientific
TMO
|
$24.1M |
| 3 |
Microsoft
MSFT
|
$23.9M |
| 4 |
Amazon
AMZN
|
$20M |
| 5 |
Visa
V
|
$20M |
Sector Composition
| 1 | Technology | 17.33% |
| 2 | Consumer Discretionary | 16.66% |
| 3 | Healthcare | 16.51% |
| 4 | Financials | 16.41% |
| 5 | Communication Services | 11.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Centene
CNC
$14.8B
| $28.2M | 0.31% |
334,756
| – | – |
|
27
Align Technology
ALGN
$9.59B
| $27.7M | 0.3% |
63,428
+4,000
| +7% | +$1.74M |
|
|
28
NovoCure
NVCR
$1.35B
| $24.6M | 0.27% |
296,784
+55,000
| +23% | +$4.56M |
|
|
AXNX
29
DELISTED
Axonics, Inc. Common Stock
AXNX
| $23.8M | 0.26% |
380,400
| – | – |
|
30
Exact Sciences
EXAS
$9.33B
| $23.8M | 0.26% |
340,205
+7,864
| +2% | +$550K |
|
31
Humana
HUM
$37.5B
| $22.8M | 0.25% |
52,459
-15,000
| -22% | -$6.53M |
|
32
Teleflex
TFX
$5.57B
| $20.6M | 0.22% |
58,000
| – | – |
|
|
BHVN
33
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $20.5M | 0.22% |
172,498
-40,000
| -19% | -$4.74M |
|
34
Illumina
ILMN
$15.2B
| $20.3M | 0.22% |
57,978
| – | – |
|
|
OSH
35
DELISTED
Oak Street Health, Inc.
OSH
| $18.9M | 0.21% |
704,933
+300,000
| +74% | +$8.06M |
|
36
Insulet
PODD
$24.2B
| $16.8M | 0.18% |
62,908
| – | – |
|
37
BioMarin Pharmaceuticals
BMRN
$11.3B
| $16.5M | 0.18% |
213,851
| – | – |
|
38
Infosys
INFY
$69B
| $16.2M | 0.18% |
649,272
-21,192
| -3% | -$527K |
|
|
39
Krystal Biotech
KRYS
$4.35B
| $15M | 0.16% |
225,809
+40,000
| +22% | +$2.66M |
|
40
iRhythm Technologies
IRTC
$5.67B
| $12.6M | 0.14% |
80,000
| – | – |
|
|
41
Teladoc Health
TDOC
$1.37B
| $12.1M | 0.13% |
168,000
+80,000
| +91% | +$5.77M |
|
42
Coherus Oncology, Inc. Common Stock
CHRS
$146M
| $12M | 0.13% |
928,464
| – | – |
|
43
Glaukos
GKOS
$5.42B
| $11.4M | 0.12% |
197,212
| – | – |
|
44
QuidelOrtho
QDEL
$1.87B
| $11.2M | 0.12% |
100,000
| – | – |
|
45
Karyopharm Therapeutics
KPTI
$61.4M
| $11.1M | 0.12% |
1,500,000
| – | – |
|
46
Service Corp International
SCI
$10.9B
| $10.7M | 0.12% |
162,338
+25,688
| +19% | +$1.69M |
|
|
AERI
47
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $10.5M | 0.11% |
1,156,142
| – | – |
|
48
Sarepta Therapeutics
SRPT
$1.98B
| $9.4M | 0.1% |
120,329
| – | – |
|
49
Synopsys
SNPS
$110B
| $8.41M | 0.09% |
25,241
+2,680
| +12% | +$893K |
|
50
Insmed
INSM
$30.3B
| $8.06M | 0.09% |
343,110
| – | – |
|